 Concomitant pelvic irradiation mitomycin treatment advanced cervical carcinoma Phase II study late FIGO Stage IIb Stage III patients External beam radiotherapy days week cm parallel pelvic fields first patients Gy mid-plane dose fractions Days last patients Gy fractions intracavitary boost Gy fractions days first patients concomitant maximum g/day mitomycin maximum mg patients WHO Grade cytopenia able full dose intensity dose Days Day Treatment morbidity reduced chemotherapy intensity comparable radiotherapy Median follow-up months Median survival months results historical controls radiation method Two-year survival late Stage IIb patients combination radiotherapy Stage III Two-year pelvic control late Stage IIb combination Stage III contrast reports centres results overall significant improvement radiotherapy Phase III study practicable